AGP Picks
View all

The Asia Pacific Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Pacific Examiner.

Press releases published on November 9, 2026

BridgeBio to Participate in November and December Investor Conferences
CervoMed Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
Lahontan Plans Drilling to Test Historic Waste Rock at Santa Fe – A Potential Source of Additional Low Cost Gold Production
Foghorn Therapeutics Provides Third Quarter 2026 Financial and Corporate Update
BIOMASER Previews Black Friday and Cyber Monday Offers: 25% Off and Free Machines with Selected Supply Bundles
Data Center Cooling CDU Pumps Market to Reach USD 5,500.47 Million by 2035 as AI Racks Move to Liquid Cooling and Megawatt-Scale CDUs
Neulasta Market Trends and Forecast Analysis Highlight Significant Long-Term Growth Potential
Detailed Neumega Market Analysis Includes Forecasts, Innovations, and Industry Perspectives
Mvabea Market Outlook Report Including Segment Evaluation and Strategic Industry Perspectives
Myobloc Market Report Covers Important Segments, Regional Developments, and Leading Competitors
Kaspi.kz 3Q & 9M 2026 Financial Results
Notice of Extraordinary General Meeting of Shareholders of Kaspi.kz
Neorecormon Market Research Report Providing Analysis of Growth, Segments, and Key Competitors
韓国Korea Nakajo、自販機向け製氷ユニットの技術を生かした「ICEVAN」を紹介
Mumps Vaccine (MumpsVax) Market Analysis Report Examining Demand Patterns and Competitive Landscape
Myalept Market Forecast to 2030: Analysis of Market Size, Growth Rate, Trends, and Projections
Zenas BioPharma to Present at the Jefferies London Global Healthcare Conference
Adagene Announces Completion of Enrollment in Randomized Dose Optimization Phase 2 Trial of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
J-Star Holding Co., Ltd. Highlights U.S. Operational Progress with Delegation Visit from Global Tier 1 Carbon Fiber Manufacturer
Marengo Presents Interim Phase 2 STARt-002 Results for First-in-Class Selective T-Cell Agonist Invikafusp Alfa Plus Sacituzumab Govitecan Across Two Metastatic Breast Cancer Cohorts in Oral Presentation at SITC 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Asia Pacific Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.